On June 1 and June 2, CancerLinQ LLC Chief of Strategic Alliances Jennifer L. Wong spoke at the “Big Data in Oncology” session at an ASCO Annual Meeting 2017 seminar titled “The Economics of Cancer Care.”
Wong spoke about how “CancerLinQ is the convener of the cancer community” and has been creating value with collaborators across the entire care continuum through coalition building. With innovative models and emerging opportunities for quality-of-care improvements, Wong shared her perspective on the evolving uses of big data in oncology and the impact CancerLinQ will have on the future of cancer care.
“CancerLinQ is a public good,” Wong said. “Our purpose is to create a learning ecosystem where we learn from every cancer patient and her journey in the real-world setting. We intend to harness the ever-growing amounts of health care data to generate insights, create new knowledge, and drive actionable change, impacting behaviors and transforming the practice of medicine. This democratization of knowledge will help our patients, providers, and partners everywhere.”
The two-day seminar was aimed at informing oncology professionals about cancer economics, such as lessons learned and best practices in the areas of innovative reimbursement, coverage, and treatment models, as well as clinical trial costs and trends in overall cancer treatment spending. The goal is to allow these professionals to make better-informed decisions in their relations with patients, payers, and other stakeholders.
Wong spoke alongside leaders from the U.S. Department of Veterans Affairs, U.S. Food and Drug Administration, and National Cancer Institute.